Is it still clinically and economically viable in the UK to prescribe vacuum erection devices for patients with erectile dysfunction after radical prostatectomy?

MeSH terms

• Cost-Benefit Analysis
• Erectile Dysfunction / economics
• Erectile Dysfunction / therapy*
• Humans
• Male
• Phosphodiesterase 5 Inhibitors / economics
• Phosphodiesterase 5 Inhibitors / therapeutic use
• Practice Patterns, Physicians' / economics
• Prescriptions / economics*
• Prostatectomy / adverse effects*
• Prostatectomy / economics
• United Kingdom
• Vacuum